Repro Med Systems Stock Return On Asset
Repro Med Systems fundamentals help investors to digest information that contributes to Repro Med's financial success or failures. It also enables traders to predict the movement of Repro OTC Stock. The fundamental analysis module provides a way to measure Repro Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Repro Med otc stock.
Repro |
Repro Med Systems OTC Stock Return On Asset Analysis
Repro Med's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Repro Med Return On Asset | 10.67 |
Most of Repro Med's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Repro Med Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Repro Med Systems has a Return On Asset of 10.67. This is 221.94% lower than that of the Healthcare sector and 136.78% lower than that of the Medical Instruments & Supplies industry. The return on asset for all United States stocks is notably lower than that of the firm.
Repro Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repro Med's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Repro Med could also be used in its relative valuation, which is a method of valuing Repro Med by comparing valuation metrics of similar companies.Repro Med is currently under evaluation in return on asset category among related companies.
Repro Fundamentals
| Return On Equity | 0.27 | |||
| Return On Asset | 10.67 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 9.81 % | |||
| Current Valuation | 131.75 M | |||
| Shares Outstanding | 38.38 M | |||
| Shares Owned By Insiders | 44.43 % | |||
| Shares Owned By Institutions | 17.96 % | |||
| Price To Earning | 393.75 X | |||
| Price To Book | 16.13 X | |||
| Price To Sales | 8.02 X | |||
| Revenue | 19.14 M | |||
| Gross Profit | 10.81 M | |||
| EBITDA | 2.21 M | |||
| Net Income | 24.21 K | |||
| Cash And Equivalents | 3.81 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 444.08 K | |||
| Debt To Equity | 4.60 % | |||
| Current Ratio | 5.30 X | |||
| Book Value Per Share | 0.25 X | |||
| Cash Flow From Operations | (960.03 K) | |||
| Number Of Employees | 75 | |||
| Beta | 0.03 | |||
| Market Capitalization | 153.54 M | |||
| Total Asset | 8.34 M | |||
| Retained Earnings | 3.02 M | |||
| Working Capital | 5.6 M | |||
| Current Asset | 7.01 M | |||
| Current Liabilities | 1.41 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Repro OTC Stock
If you are still planning to invest in Repro Med Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Repro Med's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |